Articles Dan Leeson Options Stock Market Stock Picks

TXG Continues Hitting New Highs

Dan Leeson Identifies TXG as another stock that continues to hit new highs thanks to recent acquisitions. How high can TXG go?

I noticed 10x Genomics (TXG) is on the chart for the sixth time in the row. In September, they kept their “Buy” rating from B of A securities and they just purchased two different research companies (along with their patents). Volume is about 25% higher than average and while the price had been up and down on my daily charts, it has finally hit a steady stride upward. September 15th JP Morgan rated the stock “Overweight”, September 9th Morgan Stanley initiated them at “Overweight” as well.

While I don’t always believe any one company’s rating making or breaking an entry, I do take notice when a price is steadily rising along with a string of analysts rating the company well. Another noteworthy aspect is that 10x Genomics has made two recent acquisitions. As we’re seeing right now with AMD making a move to purchase Xilinx (XLNX) typically the company doing the acquiring will show a share price drop in the short term, but then it should rise to meet the new value of the larger company. TXG is certainly showing what a stock can do post acquisition and I’m eager to see how high it can go!

Want More Picks?

Leave a Reply

Your email address will not be published.